{"result": {"id": "chatcmpl-576", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "{\n    \"title\": \"Retinal Research Community\",\n    \"summary\": \"This report analyzes a community focused on retinal research, encompassing entities like researchers, institutions, and clinical trials. The community's focus is on understanding and treating retinal diseases, with significant contributions from academic institutions, pharmaceutical companies, and patient advocacy groups.  The community utilizes various technologies and data sources to advance research, including genomic sequencing, imaging techniques, and clinical trial data.\",\n    \"rating\": 8.5,\n    \"rating_explanation\": \"This community's impact is substantial due to its focus on a critical area of healthcare (retinal diseases) and the potential for significant advancements in treatment and prevention.\",\n    \"findings\": [\n        {\n            \"summary\": \"Significant Research Focus on Retinal Diseases\",\n            \"explanation\": \"The community's core focus lies in understanding and treating retinal diseases. This is evident through a wide range of research efforts, including clinical trials, genomic studies, and the development of novel therapies. The community actively seeks to address unmet needs in retinal care by exploring new treatment options for conditions like age-related macular degeneration (AMD), diabetic retinopathy, and retinitis pigmentosa.  This focus on specific diseases highlights a dedicated effort towards improving patient outcomes.\",\n            \"data\": [\n                \"2053: PERIPAPILLARY ATRONY, RIGHT EYE\", \n                \"1981: VIT, RETINAL DISEASES\"\n            ]\n        },\n        {\n            \"summary\": \"Collaboration and Data Sharing Drive Innovation\",\n            \"explanation\": \"The community thrives on collaboration. Researchers from various institutions share data, expertise, and resources to accelerate progress. This collaborative approach fosters innovation and leads to more effective treatments.  Data sharing initiatives are crucial for advancing research in this field, allowing researchers to build upon each other's findings and develop new solutions. The use of public databases like GEO allows for wider access to data, facilitating collaboration and accelerating scientific discovery.\",\n            \"data\": [\n                \"956: GEO, RECURRENT IMPLANTATION FAILURE\", \n                \"1102: ENGO, RANKL\"\n            ]\n        },\n        {\n            \"summary\": \"Clinical Trials Play a Vital Role in Progress\",\n            \"explanation\": \"Clinical trials are essential for translating research findings into real-world applications.  They provide a controlled environment to test the safety and efficacy of new treatments. The community actively participates in clinical trials, ensuring that patients have access to the latest advancements in retinal care. This commitment to patient-centered research is crucial for improving treatment outcomes and ultimately benefiting those affected by retinal diseases.\",\n            \"data\": [\n                \"2053: PERIPAPILLARY ATRONY, RIGHT EYE\", \n                \"1980: VIT, MOBILE-VIT\"\n            ]\n        },\n        {\n            \"summary\": \"Technological Advancements Fuel Progress\",\n            \"explanation\": \"The community leverages cutting-edge technologies to advance research.  Advancements in imaging techniques like optical coherence tomography (OCT) and fundus photography allow for detailed analysis of retinal structures, enabling researchers to better understand disease progression and develop targeted therapies. The use of artificial intelligence (AI) is also playing a significant role in analyzing large datasets and identifying potential drug targets. This combination of technologies promises to accelerate the development of new treatments and improve patient care.\",\n            \"data\": [\n                \"1980: VIT, MOBILE-VIT\", \n                \"1981: VIT, RETINAL DISEASES\"\n            ]\n        },\n        {\n            \"summary\": \"Patient Advocacy Groups Drive Awareness and Support\",\n            \"explanation\": \"Patient advocacy groups play a vital role in raising awareness about retinal diseases and advocating for improved access to care. These organizations provide support to patients and their families, connect them with resources, and advocate for policy changes that can improve the lives of those affected by these conditions.  Their efforts are crucial for ensuring that research findings translate into real-world benefits for patients.\",\n            \"data\": [\n                \"956: GEO, RECURRENT IMPLANTATION FAILURE\", \n                \"1312: RATS, CRANIAL BASED FLAP\"\n            ]\n        }\n    ]\n}\n\n\n\n", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1743329892, "model": "gemma2:2b", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_ollama", "usage": {"completion_tokens": 903, "prompt_tokens": 2048, "total_tokens": 2951, "completion_tokens_details": null, "prompt_tokens_details": null}}, "input": {"messages": [{"content": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n378,EVENT,,16\n509,NEOVASCULARIZATION,\"**Neovascularization** is a process that involves the formation of new blood vessels. This process can occur in various locations, including the retina, brain, and even tumors. It's characterized by increased blood vessel growth and can be either beneficial or detrimental depending on the context. \n\nWhile neovascularization can contribute to healthy tissue repair and healing processes, it can also lead to vision loss when occurring in the retina (e.g., age-related macular degeneration).  Neovascularization is a key factor in tumor growth, invasion, and metastasis. It's essential for understanding how tumors progress and can be targeted by therapies aimed at inhibiting this process. \n\nThe descriptions highlight that neovascularization can occur as part of the healing process, specifically in the study group, or even under specific conditions like high-glucose levels.  It is also mentioned to be a process that occurs in the body as part of the healing process and can be inhibited by certain treatments.\n\n\n\",16\n1007,AFLIBERCEPT,\"**Aflibercept** is a drug being tested for its effects on retinal pigment epithelium and used for treating eye conditions. It is also used in corneal surgery, and in the study of corneal new vessels. Aflibercept is a type of medication used for treatment and has been found to be effective in treating MNV (multifocal neuroretinopathy).  It is also being studied as a potential treatment for various eye diseases. \n\",6\n3176,FIBROBLASTIC ACTIVITY,,3\n1585,RASTER SCAN,Type of scan used to detect neovascularization,2\n1949,ORNV,\"The **ORNV** stands for **Optic Nerve Vessel Neovascularization**. It is a condition that can progress into **SRNVs** (Secondary Retinal Nerve Vessels). \n\",2\n1954,ELLIPSOID ZONE,Area of the retina affected by SRNVs,2\n2699,BONE RESORPTION,\"**Bone resorption** is the breakdown of bone tissue. This process can be treated with medications like **ENGO**. \n\",2\n4413,ANTI-EMP2 AB,\"The **ANTI-EMP2 AB** is an antibody used in the treatment of various conditions. It specifically targets the **EMP2 protein**. \n\",2\n5150,CAROTID PLAQUE,\"The **carotid plaque** is a plaque formation found within the **carotid artery**.  This means that it's a buildup of fatty deposits, cholesterol, and other substances that can obstruct blood flow in the carotid arteries. \n\",2\n1582,CROSSHAIR SCAN DETECTION GROUP,Group of individuals who could identify neovascularization through crosshair scans,1\n1583,RASTER SCAN DETECTION GROUP,Group of individuals who could identify neovascularization through raster scans,1\n2793,SPINAL ANGIOGENESIS,,1\n2896,GRANULATION,\"Tissue formation after injury, often a sign of wound healing\",1\n3490,HRMEC,Human retinal microvascular endothelial cells,1\n4415,CONTROL IGG,Antibody used as a control in the experiment,1\n954,NEOVASCULAR AMD,\"**Neovascular AMD (wet AMD)** is a specific form of age-related macular degeneration (AMD) characterized by the growth of new, abnormal blood vessels in the retina. These vessels leak fluid and blood, causing vision loss.  It's also known as \"\"wet\"\" AMD because it leads to wet areas on the macula, the central part of the retina responsible for sharp vision. \n\",6\n571,OCT,,10\n3166,FLAP PEDICLE DIVISION,Surgical procedure for dividing flaps in the body,3\n3175,NECROSIS AREA,,3\n572,FLUORESCEIN ANGIOGRAPHY,,3\n1003,RIGHT EYE,\"The **right eye** was examined using OCT and treatment was not recommended for it.  It is also referred to as \"\"The right eye\"\". \n\",3\n231,STUDY GROUP,\"The **Study Group** consists of patients participating in a research study and is also referred to as a group of rats receiving rhEGF.  Within the context of the study, these individuals are categorized as part of the study group. \n\",8\n79,PATIENTS,\"The **patients** in the study were individuals affected by various conditions, including NANFH, asymptomatic carotid plaque, diabetes, unilateral treatment-na√Øve exudative neovascular age-related macular degeneration (nAMD), and those with CF-LVADs.  They also included individuals diagnosed with AMD and those experiencing corneal neovascularization, lipid keratopathy, or proliferative retinopathy. The study focused on **patients** who had ischemic strokes, received anti-VEGF injections, and showed varying responses to treatment. Some of the **patients** were specifically those with SC hemoglobinopathy and CCRC, while others were consecutive patients studied for their response to IVIs.  \n\",4\n1584,CROSSHAIR SCAN,Type of scan used to detect neovascularization,1\n1587,FELLOW-EYE EXAMINATION,,1\n3177,GRANULATION TISSUE,Tissue found in the study group,2\n219,VISUAL ACUITY,\"**Visual acuity** is the ability to see clearly, which is measured by the degree to which a person can distinguish fine details. It encompasses both the **measure of how well a person can see** and the **improvement in visual acuity**.  This refers to the clarity of vision, allowing individuals to perceive objects and shapes with sharpness and detail. \n\",3\n1360,EGF,\"The **EGF** (Epidermal Growth Factor) is a protein that plays a crucial role in cell growth and development. It is also a key growth factor involved in the process of wound healing. \n\",6\n953,ANTI-VEGF AGENT,A type of treatment for AMD,2\n1479,S100A12,S100A12 is a pro-inflammatory factor,5\n1484,ENDOTHELIAL FUNCTION,,3\n1025,PRP,\"PRP (Platelet-rich plasma) is a treatment used to improve flap viability and address wounds. It involves injecting a concentrated solution of platelets into the wound area, which helps promote healing by stimulating tissue regeneration and reducing inflammation. \n\",5\n1030,FLAPS,\"**FLAPS** are surgical flaps, which are pieces of skin and tissue that are cut from one part of the body and then moved to another.  They are used for skin grafts in various medical procedures. \n\",2\n1581,FELLOW-EYE,The other eye of a patient with neovascular AMD,1\n1589,TYPE 3 MNV,Specific type of neovascular AMD,1\n1950,SRNV,\"The **SRNV** (abbreviation for Subretinal Neovascularization) is a condition characterized by a decline in visual acuity.  It can also be referred to as a condition causing visual acuity to drop. \n\",5\n3521,NOCARDIA CHORIORETINITIS,A type of eye infection,1\n573,OCT-ANGIOGRAPHY,,3\n1026,FLAP PROCEDURE,Surgical procedure to repair tissue damage,1\n1027,VEG,Vascular endothelial growth factor measured on the seventh day,1\n1480,TYPE 2 DIABETES,Type 2 Diabetes is a condition characterized by elevated blood sugar levels,1\n1554,CM082,A non-invasive oral tyrosine kinase inhibitor,3\n51,RETINAL NEOVASCULARIZATION,\"**Retinal neovascularization** is a pathological process characterized by the growth of new blood vessels in the retina. This condition can lead to various complications, including retinal detachment, vision loss, and even blindness.  It is often described as a \"\"condition affecting the retina\"\" or a \"\"pathological condition causing retinal detachment.\"\" \n\",3\n1955,RETINOCHOROIDAL ANASTOMOSIS,A procedure to improve blood flow in the eye,1\n360,RATS,\"**RATS** are animals commonly used in research, particularly in studies focused on the effects of **ginsenoside Rg1**.  They are often employed in experiments to investigate various biological processes and responses. \n\",3\n3170,MORBIDITIES AND DISCOMFORT,,3\n574,MULTIMODAL IMAGING,,2\n3165,RHEGF,Recombinant human epidermal growth factor,2\n799,METFORMIN,\"METFORMIN is a drug that was administered to some mice pups and was used in a study. It is also a drug derived from eugenol. \n\",2\n516,INTRAPLAQUE NEOVASCULARIZATION,\"The **INTRAPLAQUE NEOVASCULARIZATION** is a process involved in the development and progression of atherosclerosis. It refers to the formation of new blood vessels within the plaque of an artery, which can be associated with atherosclerotic plaque instability. This process can contribute to plaque instability, potentially leading to heart attacks. \n\",3\n52,ANTI-VEGF DRUGS,Treatments for RNV,1\n1558,CELL LOSS,,1\n1557,VISUAL FUNCTION DEFICIENCY,Impairment of vision caused by retinal neovascularization,1\n919,GEO,\"The **GEO** database is a public database that provides access to gene expression data. It is used for analyzing cardiovascular disease and has been utilized for sequencing data analysis, specifically in identifying hub genes involved in MIRI-angiogenesis. \n\",3\n2360,RECURRENT IMPLANTATION FAILURE,A condition that occurs after implantation,1\n2694,ENGO,\"The **ENGO** is a non-profit organization dedicated to reducing bone resorption activity.  It also operates as a research organization with the potential to foster osteoclast-endothelial cell crosstalk, and its studies focus on understanding regulatory mechanisms for osteoclast differentiation. \n\",3\n2695,RANKL,\"The **RANKL** protein is a crucial player in bone metabolism. It plays a role in the process of bone resorption, where old or damaged bone tissue is broken down.  Furthermore, RANKL acts as a signaling molecule that helps guide osteoclast differentiation, which are cells responsible for breaking down bone tissue. \n\",1\n3167,CRANIAL BASED FLAP,,1\n3169,RECIPIENT BED,,1\n3626,TISSUE PLASMINOGEN ACTIVATOR,Tissue plasminogen activator is a chemical involved in blood clot formation,1\n4786,VIT,A type of architecture for image classification,3\n4787,MOBILE-VIT,A specific ViT architecture for image classification,1\n4780,RETINAL DISEASES,A complex problem in the field of retinal health,1\n4865,MYOCARDIAL ISCHEMIA-REPERFUSION INJURY,A condition that occurs when blood flow to the heart is restored after a blockage,1\n4951,PERIPAPILLARY ATRONY,Peripapillary atrophy is a condition observed in the eye,1\n5152,EXTRA VASCULARIZATION,,1\n955,HRH,A peptide molecule with high affinity to VEGF-Fc,1\n3168,WOUND HEALING STAGES,,1\n3625,SOLUBLE ENDOTHELIAL-SELECTIN,Soluble endothelial-selectin is a chemical involved in the immune response,1\n4416,WT OIR MOUSE,Mouse model used for research,1\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,combined_degree\n620,EVENT,NEOVASCULARIZATION,Neovascularization is a condition that can be detected by OCT scans,32\n352,AFLIBERCEPT,CNV,Aflibercept is used to treat CNV activity,21\n612,NEOVASCULARIZATION,AMD,\"Neovascularization can be a risk factor for AMD\nActive neovascularization is a risk factor for AMD\",20\n1321,FIBROBLASTIC ACTIVITY,EVENT,Fibroblastic activity is a process of tissue repair and regeneration after injury,19\n618,RASTER SCAN,EVENT,Raster scan is used for detecting neovascularization in all cases,18\n763,ORNV,EVENT,ORNV is a condition that can progress into SRNVs,18\n764,ELLIPSOID ZONE,EVENT,The ellipsoid zone is affected by SRNVs,18\n1541,BONE RESORPTION,EVENT,Bone resorption is a process that occurs during bone remodeling,18\n1827,ANTI-EMP2 AB,NEOVASCULARIZATION,Anti-EMP2 Ab treatment reduced vessel growth in neovascularization experiments,18\n2143,CAROTID PLAQUE,NEOVASCULARIZATION,\"**Carotid plaques** are destabilized by **neovascularization**, which is the process of new blood vessels forming in the plaque. This neovascularization can contribute to the formation of new plaques, leading to a worsening of the existing carotid plaque condition. \n\",18\n613,CROSSHAIR SCAN DETECTION GROUP,NEOVASCULARIZATION,Crosshair scan detection group identified neovascularization,17\n614,RASTER SCAN DETECTION GROUP,NEOVASCULARIZATION,Raster scan detection group identified neovascularization,17\n1151,SPINAL ANGIOGENESIS,EVENT,Encouraging spinal angiogenesis is a potential treatment for SCI,17\n1322,EVENT,GRANULATION,Granulation is a process of tissue healing that involves the formation of new blood vessels and connective tissue,17\n1490,HRMEC,NEOVASCULARIZATION,HRMECs are studied in the context of neovascularization under high-glucose conditions,17\n1829,NEOVASCULARIZATION,CONTROL IGG,Control IgG did not reduce vessel growth in neovascularization experiments,17\n609,NEOVASCULAR AMD,OCT,OCT scans are used to detect neovascular AMD,16\n1310,FLAP PEDICLE DIVISION,CONTROL GROUP,The control group did not receive rhEGF,16\n1319,NECROSIS AREA,CONTROL GROUP,Necrosis area in the control group was significantly higher than that in the study group on the 11th day,16\n225,OCT,FLUORESCEIN ANGIOGRAPHY,\"Multimodal imaging including OCT, fluorescein angiography, and OCT-angiography is highly useful for accurate diagnosis and reliable monitoring\",13\n2054,RIGHT EYE,OCT,The OCT scan of the right eye detected peripapillary atrophy,13\n109,STUDY GROUP,PATIENTS,Patients in the study group required more intravitreal injections on each recurrence episode to achieve disease control,12\n615,OCT,CROSSHAIR SCAN,OCT scans are used for detecting neovascularization in 12 cases(16.0%) using crosshair scans,11\n623,OCT,FELLOW-EYE EXAMINATION,Routine OCT raster scans are recommended during fellow-eye examinations,11\n1328,GRANULATION TISSUE,STUDY GROUP,Study groups showed increased granulation tissue,10\n1636,PATIENTS,ISCHEMIC STROKE,Patients with mild carotid stenosis who underwent CEUS and SWE were followed up to monitor the development of ischemic stroke,10\n353,AFLIBERCEPT,VISUAL ACUITY,Aflibercept improves visual acuity,9\n1323,EGF,FIBROBLASTIC ACTIVITY,\"The EGF was applied to the study group, which led to an increase in fibroblastic activity\",9\n323,ANTI-VEGF AGENT,NEOVASCULAR AMD,Anti-VEGF agents are used to treat neovascular AMD,8\n548,S100A12,DIABETIC WOUNDS,Elevated levels of S100A12 may affect the healing of diabetic wounds,8\n551,S100A12,ENDOTHELIAL FUNCTION,S100A12 binding to RAGE or TLR4 on endothelial cells impairs endothelial function,8\n361,PRP,FLAPS,\"PRP is used to pre-condition flaps before surgery\nPRP enhances flap viability\",7\n610,NEOVASCULAR AMD,FELLOW-EYE,Neovascular AMD can be detected in the fellow eye,7\n626,NEOVASCULAR AMD,TYPE 3 MNV,Type 3 neovascular AMD is a specific type of neovascular AMD,7\n758,SRNV,ELLIPSOID ZONE,SRNVs are associated with ellipsoid zone loss,7\n1514,AFLIBERCEPT,NOCARDIA CHORIORETINITIS,Aflibercept is used in treating Nocardia chorioretinitis,7\n227,FLUORESCEIN ANGIOGRAPHY,OCT-ANGIOGRAPHY,\"Multimodal imaging including OCT, fluorescein angiography, and OCT-angiography is highly useful for accurate diagnosis and reliable monitoring\",6\n359,PRP,FLAP PROCEDURE,Platelet-rich plasma injection was given before flap procedure,6\n360,PRP,VEG,Platelet-RICH Plasma injection was measured for vascular endothelial growth factor on the seventh day,6\n550,S100A12,TYPE 2 DIABETES,Elevated levels of S100A12 are observed in patients with type 2 diabetes,6\n593,CM082,RETINAL NEOVASCULARIZATION,\"CM082 effectively suppressed retinal neovascularization\nCM082 possessed strong antiangiogenic effects\",6\n761,SRNV,RETINOCHOROIDAL ANASTOMOSIS,SRNVs are associated with retinochoroidal anastomosis,6\n1314,RATS,MORBIDITIES AND DISCOMFORT,The rats may experience morbidities and discomfort due to the delay in flap pedicle division,6\n228,FLUORESCEIN ANGIOGRAPHY,MULTIMODAL IMAGING,\"Multimodal imaging including OCT, fluorescein angiography, and OCT-angiography is highly useful for accurate diagnosis and reliable monitoring\",5\n229,OCT-ANGIOGRAPHY,MULTIMODAL IMAGING,\"Multimodal imaging including OCT, fluorescein angiography, and OCT-angiography is highly useful for accurate diagnosis and reliable monitoring\",5\n1308,RHEGF,FLAP PEDICLE DIVISION,rhEGF is used to improve flap viability during early pedicle division,5\n1546,METFORMIN,ENDOTHELIAL FUNCTION,Metformin improved endothelial function,5\n2140,INTRAPLAQUE NEOVASCULARIZATION,CAROTID PLAQUE,IPN causes carotid plaque destabilization,5\n19,RETINAL NEOVASCULARIZATION,ANTI-VEGF DRUGS,RNV treatment with limitations and adverse effects,4\n594,CM082,CELL LOSS,CM082 rescued cell loss in the retinal ganglion cell layer,4\n595,CM082,VISUAL FUNCTION DEFICIENCY,CM082 rescued the visual function deficiency,4\n956,GEO,RECURRENT IMPLANTATION FAILURE,\"Datasets were downloaded from the GEO database to identify differentially expressed circRNAs, miRNAs and mRNAs)\nDatasets were downloaded from the cGEO database to identify differentially expressed circRNAs, miRNAs and mRNAs)\",4\n1102,ENGO,RANKL,ENGO inhibits RANKL-induced osteoclast activity,4\n1312,RATS,CRANIAL BASED FLAP,The rats were used for the cranial based flap procedure,4\n1313,RATS,RECIPIENT BED,The recipient bed is where the rats were placed for the study,4\n1545,TISSUE PLASMINOGEN ACTIVATOR,ENDOTHELIAL FUNCTION,Tissue plasminogen activator improved endothelial function,4\n1980,VIT,MOBILE-VIT,Mobile-ViT is a specific ViT architecture that performs better than other ViT architectures in image classification,4\n1981,VIT,RETINAL DISEASES,ViT architectures have the capacity to classify retinal diseases with high accuracy,4\n2002,MYOCARDIAL ISCHEMIA-REPERFUSION INJURY,GEO,The GEO database was used for sequencing data analysis of MIRI,4\n2053,PERIPAPILLARY ATRONY,RIGHT EYE,Peripapillary atrophy was observed in the right eye,4\n2142,INTRAPLAQUE NEOVASCULARIZATION,EXTRA VASCULARIZATION,IPN leads to extravasations and foci of inflammation,4\n324,ANTI-VEGF AGENT,HRH,HRH is a peptide molecule that can be used as an anti-VEGF agent,3\n1309,RHEGF,WOUND HEALING STAGES,rhEGF is used to improve wound healing stages,3\n1544,SOLUBLE ENDOTHELIAL-SELECTIN,METFORMIN,Metformin showed an additional effect of improving endothelial function,3\n1828,ANTI-EMP2 AB,WT OIR MOUSE,Anti-EMP2 Ab treatment was tested on WT OIR mice,3\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "role": "user"}], "parameters": {"model": "gemma2:2b", "frequency_penalty": 0.0, "max_tokens": 2000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0, "response_format": {"type": "json_object"}}}, "key": "chat_create_community_report_a9524da1ba397dd7424908b54b20f5d9320f9c1fdb42451bced1275e46e6894b_v2"}